MENU
ALPMY
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Astellas Pharma (ALPMY) Ownership - Who owns Astellas Pharma?
Profile
Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
26.55B
P/E Ratio
37.59
Total Cash
396.62B
Projected Growth
N/A
Total Debt
30B
Revenue
1.52T
Risk (Beta)
0.30
Dividend Yield
0.03
Total Cash/Share
220.74
Total Debt/Equity
N/A
Revenue/Share
5.91 USD as % of share price
Fundamentals
ALPMY
Capitalization
26.6B
P/E Ratio
37.59
Risk (Beta)
0.30
Dividend Yield
0.03
Total Cash
397B
Total Cash/Share
220.74
Total Debt
30B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.91%
Revenue
1.52T
ROE
N/A
Book Value
1.51T
P/B Ratio
2.43
Cash Flow
N/A
Earnings
54.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103B
Current Ratio
1.45
Current Revenue Per Employee
24458298.00
Dividends Per Share - Security
28.81
EBITDA
247B
Float
N/A
Float - Current
N/A
Gross Income Margin
82.42
Revenue To Assets
4.12
Shares Held By Institutions
17.1M
Shares Outstanding - Current
1.8B
Total Liabilities
949B
Total Volume MTD
N/A
Value
1
Gain YTD
-2.134
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com